Cargando…

Cellular Transcriptomics of Carboplatin Resistance in a Metastatic Canine Osteosarcoma Cell Line

Osteosarcoma prognosis has remained unchanged for the past three decades. In both humans and canines, treatment is limited to excision, radiation, and chemotherapy. Chemoresistance is the primary cause of treatment failure, and the trajectory of tumor evolution while under selective pressure from tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hodge, McKaela A., Miller, Tasha, Weinman, Marcus A., Wustefeld-Janssens, Brandan, Bracha, Shay, Davis, Brian W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048144/ https://www.ncbi.nlm.nih.gov/pubmed/36980828 http://dx.doi.org/10.3390/genes14030558

Ejemplares similares

Exosomal proteomic signatures correlate with drug resistance and carboplatin treatment outcome in a spontaneous model of canine osteosarcoma
por: Weinman, Marcus A., et al.
Publicado: (2021)

Autocrine production of reproductive axis neuropeptides affects proliferation of canine osteosarcoma in vitro
por: Weinman, Marcus A., et al.
Publicado: (2019)

Quantification of Canine Apocrine Gland Anal Sac Adenocarcinoma (AGASACA) Tumor Specimen Shrinkage after Formalin Fixation
por: Wustefeld-Janssens, Brandan G., et al.
Publicado: (2022)

The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro
por: Marley, Kevin, et al.
Publicado: (2013)

Comparative analysis of the surface exposed proteome of two canine osteosarcoma cell lines and normal canine osteoblasts
por: Milovancev, Milan, et al.
Publicado: (2013)

The expression and role of serotonin receptor 5HTR2A in canine osteoblasts and an osteosarcoma cell line
por: Bracha, Shay, et al.
Publicado: (2013)

Characterization of five newly derived canine osteosarcoma cell lines
por: Wilson-Robles, Heather, et al.
Publicado: (2019)

Transient Postoperative Hemorrhage from Elbow Arthroscopy Portals following Intra-Articular Pentosan Polysulfate Sodium Injection
por: Parker, Lindsay A., et al.
Publicado: (2022)

Feasibility and safety of whole lung irradiation in the treatment of canine appendicular osteosarcoma
por: Brehm, Amanda, et al.
Publicado: (2021)

Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities
por: Song, Zifeng, et al.
Publicado: (2020)

Cellular and Phenotypic Characterization of Canine Osteosarcoma Cell Lines
por: Legare, Marie E., et al.
Publicado: (2011)

Comparative proteomic investigation of metastatic and non-metastatic osteosarcoma cells of human and canine origin
por: Roy, Jahnabi, et al.
Publicado: (2017)

ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma
por: Cam, Maren, et al.
Publicado: (2016)

Biliothorax in a Siamese cat
por: Wustefeld-Janssens, Brandan G., et al.
Publicado: (2011)

Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma
por: Marley, Kevin, et al.
Publicado: (2013)

Evaluation of Weight Change During Carboplatin Therapy in Dogs With Appendicular Osteosarcoma
por: Story, A.L., et al.
Publicado: (2017)

Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro
por: Milovancev, Milan, et al.
Publicado: (2016)

Retrospective Evaluation of a Combination of Carboplatin and Bleomycin for the Treatment of Canine Carcinomas
por: Giuliano, Antonio, et al.
Publicado: (2022)

Outcomes of Window Therapy with Carboplatin and Ifosfamide for Pediatric Osteosarcoma: A Case Series
por: Aiba, Hisaki, et al.
Publicado: (2023)

Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma
por: Regan, Daniel P., et al.
Publicado: (2022)

Expression of Nociceptive Ligands in Canine Osteosarcoma
por: Shor, S., et al.
Publicado: (2015)

Expression of Bcl-2 in canine osteosarcoma
por: Piro, F., et al.
Publicado: (2015)

Molecular Mechanisms of Canine Osteosarcoma Metastasis
por: Wilk, Sylwia S., et al.
Publicado: (2021)

Genomic and Transcriptomic Characterization of Canine Osteosarcoma Cell Lines: A Valuable Resource in Translational Medicine
por: Gola, Cecilia, et al.
Publicado: (2021)

MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines
por: Fenger, Joelle M., et al.
Publicado: (2016)

Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer
por: Yuan, Yuan, et al.
Publicado: (2023)

PEG-liposomal doxorubicin as a potential agent for canine metastatic osteosarcoma – in vitro and ex ovo studies
por: Walewska, Magdalena, et al.
Publicado: (2023)

Evaluation of canonical Hedgehog signaling pathway inhibition in canine osteosarcoma
por: Baldanza, Vincent E., et al.
Publicado: (2020)

Recent Advances in the Discovery of Biomarkers for Canine Osteosarcoma
por: Luu, Anita K., et al.
Publicado: (2021)

Expression of Sex Hormone Receptors in Canine Osteosarcoma
por: Dilley, Kristyn N., et al.
Publicado: (2022)

Metastatic Spread of Osteosarcoma
por: Price, C. H. G., et al.
Publicado: (1973)

The metastatic patterns of osteosarcoma.
por: Jeffree, G. M., et al.
Publicado: (1975)

Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches
por: Chu, Shirley, et al.
Publicado: (2021)

Whole-genome approach implicates CD44 in cellular resistance to carboplatin
por: Shukla, Sunita J, et al.
Publicado: (2009)

The effect of carboplatin on renal function in patients with metastatic germ cell tumours.
por: Mason, M. D., et al.
Publicado: (1991)

Comment on ‘The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘
por: Kitchen, D, et al.
Publicado: (2013)

Comparison of Carboplatin and Doxorubicin‐Based Chemotherapy Protocols in 470 Dogs after Amputation for Treatment of Appendicular Osteosarcoma
por: Selmic, L.E., et al.
Publicado: (2014)

Plasma Cytokeratin 18 and fecal Alpha‐1 Antitrypsin concentrations in dogs with osteosarcoma receiving carboplatin chemotherapy
por: Taikowski, Kathryn, et al.
Publicado: (2020)

Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression
por: Paoloni, Melissa, et al.
Publicado: (2009)

Genomic Instability and Telomere Fusion of Canine Osteosarcoma Cells
por: Maeda, Junko, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_idg8sm40609tvd8clbdl9jbu64